🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Sellers market the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some professionals stated the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the platform has removed violative content and banned associated hashtags and query recommendations. The company said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive reviews and detailed guides for mixing or administering at home.

Within minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.

Product Information and Costs

Inside these groups, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant health risks”.